Skip to Main Content

Paper Details

Potent neutralizing nanobodies resist convergent circulating variants of SARS-CoV-2 by targeting novel and conserved epitopes.
bioRxiv
11
2021
Author NameAffiliation
Derek J TaylorCase Western Reserve University
Derek J TaylorCase Western Reserve University
Dina Schneidman-DuhovnyInstitute of Life Sciences, The Hebrew University of Jerusalem
Dina Schneidman-DuhovnyInstitute of Life Sciences, The Hebrew University of Jerusalem
Yi ShiThe University of Pittsburgh and Carnegie Mellon University Program for Computational Biology
Yi ShiUniversity of Pittsburgh
Yi ShiUniversity of Pittsburgh School of Medicine and Carnegie Mellon University
  • 1 - 7

Datasets